People on the Move

Surefire Medical appointed Mary T. Szela as CEO and president. Szela brings nearly 30 years of experience in the biotechnology, medical products, and pharmaceutical industries. She previously served as CEO of Novelion Therapeutics, a rare disease company. Prior to Novelion, Szela was CEO of Melinta Therapeutic, and previously served at Abbott Laboratories as president of the company’s U.S. pharmaceutical business, and as vice president for global strategic marketing and services.